If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 241 - 250 of 279
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma
Objective
To find out if this approach is better or worse than the usual approach for DLBCL patients receiving CAR T-cell therapy. The usual approach for Relapsed/Refractory DLBCL patients is follow-up visits with no further therapy.
Protocol No
SWOG-S2114
Categories
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Objective
PLDR CRT for esophageal cancer
Protocol No
IIT-PUCKETT-PULSO
Categories
A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-Clinical Practice Patient Population With HR+ HER2- Early Breast Cancer
Objective
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).
Protocol No
NOVARTIS-CLEE011O12001-WIDER
Categories
Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Subacute Aphasia
Objective
Transcranial Alternating Current Stimulation (tACS) in Subacute Aphasia
Protocol No
NEURO-MCW-TACS-SUBACUTEAPHASIA
Categories
A Multicenter, Randomized, Open-Label, Phase 2 Study Evaluating the Safety and Efficacy of BMS-986504 Monotherapy in Participants with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Homozygous MTAP Deletion After Progression on Prior
Objective
Study of BMS-986504 in pre-treated advanced or metastatic NSCLC with homozygous MTAP deletion
Protocol No
BMS-CA2400009
Categories
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Objective
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Protocol No
NRG-BN003
Categories
A Multicenter Study to Assess the Safety and Effectiveness of the Genio Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Adults Subjects
Objective
Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)
Protocol No
OTO-NYXOAH-DREAM-STUDY
Categories
Every Day Counts: A Lifestyle Program for Women with Metastatic Breast Cancer
Objective
Every Day Counts: A Lifestyle Program for Women with Metastatic Breast Cancer
Protocol No
IIT-STOLLEY-EVERY-DAY-COUNTS-2
Categories
A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients with Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery
Objective
Does giving chemotherapy or chemo-immunotherapy before surgery extend the length of time without your cancer returning compared to the usual approach
Protocol No
NRG-HN015-NEOPOLIS
Categories
LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Objective
Targeted Treatment for Advanced Non-Small Cell Lung Cancer
Protocol No
SWOG-LUNGMAP
Categories